Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000. (Q43795768)

26 November 2017

Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000. (English)

1 reference

26 November 2017

0 references

1 reference

1 reference

Irani-Hakime N

1

1 reference

26 November 2017

Tamim H

series ordinal

2

1 reference

26 November 2017

Samaha H

series ordinal

3

1 reference

26 November 2017

Almawi WY

series ordinal

4

1 reference

26 November 2017

1 October 2001

1 reference

International Journal of Laboratory Hematology

26 November 2017

1 reference

26 November 2017

23

1 reference

26 November 2017

5

1 reference

26 November 2017

317-323

1 reference

Epidemiology of hepatitis C virus: a study of male blood donors in Saudi Arabia

26 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Natural history of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Discovery of non-A, non-B hepatitis and identification of its etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Hepatitis C in asymptomatic blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Epidemiology of HCV infection in the general population and in blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Reducing the risk of infection from plasma products: specific preventative strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Sexual transmission of hepatitis C virus to a repeat blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Prevalence of hepatitis C virus genotypes in southern Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

A French consensus conference on hepatitis C: screening and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Spread of hepatitis C virus among sexual partners of HCVAb positive intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Antibodies to hepatitis C virus in French blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Antibody to hepatitis C virus in German blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Large-scale HCV RNA screening in first-time blood donors: the first step towards genomic screening of blood donations. HCV RNA Screening Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Infectivity of blood seropositive for hepatitis C virus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Evaluation of abnormal liver-enzyme results in asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Prevalence of antibody to hepatitis C virus in a blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Antibodies to hepatitis C virus in Italian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

Prevalence of anti-HCV antibody in blood donors in the Tokyo area

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00409.X

10.1046/J.1365-2257.2001.00409.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference